O
AMAM

OrbiMed’s Ambrx Biopharma Inc AMAM Stock Holding History

OrbiMed’s Portfolio AMAM Stock Details AMAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-296,000
Closed -$4.22M – 129
2023
Q4 		$4.22M Buy
+296,000
New +$3.36M 0.08% 92

OrbiMed's AMAM Position: Q1 2024 in Review

OrbiMed sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 296,000 shares — an estimated $4.22M sold.

OrbiMed first reported a position in AMAM in Q4 2023 and held it in 1 quarter. The position peaked at $4.22M in Q4 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

  • OrbiMed reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • OrbiMed sold 296,000 Ambrx Biopharma Inc shares in Q1 2024, an estimated $4.22M.
  • OrbiMed first reported a position in Ambrx Biopharma Inc in Q4 2023 and held it in 1 quarter.
  • OrbiMed's Ambrx Biopharma Inc position peaked at $4.22M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on OrbiMed's 13F filing for Q1 2024, filed 15 May 2024.